Haakstad LAH, Gjestvang C, Lamerton T, Bø K Urinary incontinence in a fitness club setting-is it a workout problem? Int Urogynecol J. 2020 Mar 4. doi: 10.1007/s00192-020-04253-0. [Epub ahead of print]
Hay-Smith J, Mørkved S, Fairbrother KA, Herbison GP Pelvic floor muscle training for prevention and treatment of urinary and faecal incontinence in antenatal and postnatal women. Cochrane Database Syst Rev. 2008 Oct 8;(4):CD007471. doi: 10.1002/14651858.CD007471. Review. Update in: Cochrane Database Syst Rev. 2012;10:CD007471.
MacLennan AH, Taylor AW, Wilson DH, Wilson D The prevalence of pelvic floor disorders and their relationship to gender, age, parity and mode of delivery. BJOG. 2000 Dec;107(12):1460-70.
Titman SC, Radley SC, Gray TG Self-management in women with stress incontinence: strategies, outcomes and integration into clinical care. Res Rep Urol. 2019 Apr 17;11:111-121. doi: 10.2147/RRU.S177826. eCollection 2019.
Turner CE, Young JM, Solomon MJ, Ludlow J, Benness C Incidence and etiology of pelvic floor dysfunction and mode of delivery: an overview. Dis Colon Rectum. 2009 Jun;52(6):1186-95. doi: 10.1007/DCR.0b013e31819f283f. Review.
Wohlrab KJ, Rardin CR Impact of route of delivery on continence and sexual function. Clin Perinatol. 2008 Sep;35(3):583-90, xii. doi: 10.1016/j.clp.2008.06.001. Review.
Observational Study on the Prevalence of Urinary Incontinence in Federates Athletes in Castilla y León.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
